Respuesto, Antonio B.

HRN: 23-54-29  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/17/2023
CEFUROXIME 1.5GM (VIAL)
08/17/2023
08/24/2023
IV
1.5 G
Every 8 Hours
Incarcerated Indirect Inguinal Hernia, Right
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes